Related Experiment Video

Updated: Jun 2, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen

Ana M Mendes-Pereira1, David Sims, Tim Dexter

  • 1Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, Institute of Cancer Research, London SW3 6JB, United Kingdom.

Proceedings of the National Academy of Sciences of the United States of America
|April 13, 2011
PubMed

Insights

Researchers identified genes affecting tamoxifen response in breast cancer. This study reveals new targets for overcoming tamoxifen resistance, improving endocrine therapy effectiveness.

Area of Science:

  • Oncology
  • Genetics
  • Pharmacology

Background:

  • Estrogen signaling therapies significantly reduce breast cancer mortality.
  • Tamoxifen resistance is a major clinical challenge in breast cancer treatment.

Purpose of the Study:

  • To identify genes influencing cellular sensitivity or resistance to tamoxifen using a genome-wide approach.
  • To discover novel therapeutic targets for overcoming endocrine resistance in breast cancer.

Main Methods:

  • Genome-wide functional profiling using whole-genome shRNA screening.
  • Massively parallel sequencing to analyze the impact of over 56,670 RNA interference reagents.
  • Validation experiments to confirm identified genes.

Main Results:

  • Identified genes whose silencing confers tamoxifen resistance (e.g., BAP1, NF1, RAD21).
  • Identified genes whose silencing confers tamoxifen sensitivity (e.g., KRAS, EDF1, TPM4).
  • NF1 gene, a RAS signaling regulator, correlated with clinical outcomes post-tamoxifen treatment.

Conclusions:

  • This study provides a comprehensive gene compendium impacting tamoxifen response.
  • These findings offer potential new strategies to enhance tamoxifen efficacy and combat resistance in breast cancer.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...